Skip to main content

Advertisement

Table 3 Use of antimalarials among individuals with acute fever and treated with antimalarials (proportion estimates & 95% confidence intervals)

From: Treatment of Febrile illness with artemisinin combination therapy: prevalence and predictors in five African household surveys

  Gambia Ghana Kenya Nigeria Uganda
Artemisinin-combination theraphy      
artemether_amiodaquine - - - 0%(0%, 1%) -
artemether_lumefantrine - 4%(-1%) 30%(21%,39%) 8%(4%,11%) 36%(26%,46%)
artesunate_amodiaquine - 32%(21%,42%) - 0%(0%,1%) -
artesunate_mefloquine - - 0%(0%,1%) - -
dihydroartemisinin_piperaquine - 5%(1%,9%) 0%(0%,1%) - 1%(0%,2%)
Other Antimalarials      
SP 64%(54%,74%) 4%(0%,7%) 13%(6%,20%) 9%(3%,15%) 9%(6%,13%)
chloroquine 97%(95%,100%) 8%(1%,16%) 1%(0%,2%) 39%(29%,48%) 18%(12%,24%)
amodiaquine - 21%(13%,29%) 13%(8%,18%) 0%(0%,1%) 4%(1%,7%)
antimalarial, unspecified - 19%(11%,27%) 33%(25%,42%) 38%(27%,48%) 24%(13%,35%)
quinine 1%(0%,1%) 4%(-1%,8%) 11%(6%,15%) 1%(0%,3%) 21%(17%,25%)
artemether - 3%(0%,5%) - 3%(0%,6%) 1%(0%,1%)
artemisinin - - 1%(0%,2%) 1%(0%,2%) -
artesunate - 9%(4%,14%) - 5%(2%,8%) -
chloroquine_SP 1%(0%,2%) - - - 0%(0%,1%)
dihydroartemisinin - - 2%(0%,3%) 1%(0%,1%) -
halofantrine - - - 1%(0%,2%) -
mefloquine - - - 0%(0%,1%) -
quinine_SP - - 2%(0%,3%) - -